News zum Sektor Gesundheit aus Schweden

 

REYKJAVÍK, Iceland and LUXEMBOURG, June 03, 2026 (GLOBE NEWSWIRE) -- The 2026 Annual and Extraordinary General Meeting of Alvotech (the "2026 AGM") was held on June 3, 2026, at Arendt House, 41A Avenue John F. Kennedy, L-2082 Luxembourg. ...

Elicera Therapeutics AB (publ) (“Elicera”), a clinical stage cell and gene therapy company developing next-generation therapies based on oncolytic viruses and CAR T-cells armed with bystander immune activating properties using the company's commercially available platform iTANK, today announced that the Annual Report for 2025 has been published.     Elicera Therapeutic's annual report is available at the home.page.   Annual meeting will take place 25 June kl 13.00 at Advokatfirman Delphi (Mäster Samuelsgatan 17 in Stockholm, Sweden).   This press release has been...

Uppsala, June 3, 2026. OssDsign AB (publ.) today announces the publication of a new scientific article in The Journal of Bone and Mineral Research (JBMR). The preclinical study evaluated OssDsign Catalyst as a standalone bone graft in trauma, comparing it to an earlier-generation bone graft. The results show significantly more bone formation with OssDsign Catalyst at earlier timepoints, as well as clear evidence that the graft is naturally broken down and replaced by the body over time – reinforcing the superiority of fourth-generation synthetic bone grafts like OssDsign Catalyst. In the...

UPPSALA, SE / ACCESS Newswire / June 3, 2026 / Senzime AB (STO:SEZI)(OTCQX:SNZZF) announced today advancements within pediatric anesthesia, securing another top ranked pediatric hospital contract. ......

Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

The nomination committee of OssDsign AB (publ) (“OssDsign” or the “Company”) has updated its proposal regarding board fees ahead of the annual general meeting on 9 June 2026. The updated proposal entails that fees for work within the audit committee are added in addition to the previously proposed board fees. The nomination committee has previously proposed that the fees payable to the board of directors for the period until the end of the next annual general meeting shall amount to a total of SEK 1,300,000, out of which SEK 400,000 shall be paid to the chairman and SEK 300,000 to each of...

NOT INTENDED FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, SWITZERLAND, SINGAPORE, SOUTH ......

Peptonic Medical AB (publ) (“Peptonic” or “the Company”) is launching a new product segment within health and beauty. This initiative represents a significant broadening of the Company's product portfolio and constitutes an important step in the long-term strategy to create new revenue streams and strengthen the market position. The launch is planned for the second half of 2026. In connection with this, the Company will also bring products together under a new common brand in accordance with the strategic development plan. The first product will be an innovative dietary supplement developed...

The Board of Directors of Asker Healthcare Group AB (publ) (“Asker”) has been informed that Asker's largest shareholder, Interogo Long-Term Equity, through Strukturfonden HC15 AB (“Interogo”), has issued call options in Asker to the Chair of the Board, Mikael Stöhr. In total, 291,970 options, each entitling the holder to acquire one share, have been acquired by Mikael Stöhr at a price corresponding to market value of the options on the transaction date, based on a valuation conducted by an independent valuation institute applying the Black & Scholes valuation model. The total market value of...

HELSINKI, Finland--(BUSINESS WIRE)--Coolbrook, a transformational technology company dedicated to decarbonising heavy industry and industrial processes, has appointed renowned Finnish business leader Veli-Matti Mattila as Chairman of the Board effective immediately. Mattila brings decades of international leadership experience and board expertise to support Coolbrook's next phase of commercial growth, industrial execution, and global scale-up. Veli-Matti Mattila is one of Finland's most experienced technology business leaders, having served as CEO of Elisa Corporation from 2003 to 2024, following a long international career at Ericsson, where he held several senior leadership roles, including President of Ericsson Finland and COO & Deputy Head of Market Unit, Nordic & Baltic. He also spent four years in the U.S. and a period of time in Switzerland during his stint at Ericsson. He currently serves as Chairman of Orion Corporation and Enento Group, and has previously chaired Confederation of Finnish Indus...

GOTHENBURG, SE / ACCESS Newswire / June 3, 2026 / IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, announces that CEO Kr......

REYKJAVIK, ICELAND (June 2, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that Robert Wessman, Alvotech's Founder and Executive Chairman, and Dr. Balaji V. Prasad, Chief Strategy Officer, will participate in the upcoming investor conferences in June as follows:...

Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

The press release was sent 2026-06-02 at 16:16 without information about the interest rate. The interest rate is stated in bold in the press release below which is otherwise consistent with the previously issued press release. Scandinavian ChemoTech has secured a SEK 6 million growth loan from a larger financial institution in Sweden. The financing forms part of ChemoTech's long-term financial strategy and will support the Company's commercial expansion within Animal Care in North America and Europe. By strengthening sales and marketing capacity, the loan is expected to contribute to...

Getinge today announced the launch of the Vasoview Hemopro 3 Endoscopic Vessel Harvesting (EVH) System, including the Hemopro 3 Harvesting Tool and dedicated Hemopro 3 Power Supply. Designed for clinicians, by clinicians, the system represents the latest evolution of Getinge's EVH platform, enhancing decades of experience supporting coronary artery bypass grafting (CABG) procedures. [image] Endoscopic vessel harvesting is a minimally invasive technique used to obtain blood vessels, most commonly the saphenous vein or radial artery, for use in CABG surgery. Vessel harvesting plays a...

ODI Pharma AB (“ODI” or the “Company”) announces that it has completed the final repayment of its outstanding working capital loan and is now debt-free. Volker Wiederrich, Chairman of the Board, ODI Pharma, comments: "The full repayment of the loan marks the completion of a financing arrangement that supported the Company's commercial expansion. With no remaining interest-bearing liabilities, ODI Pharma enters its next phase with a strengthened balance sheet and increased financial flexibility." The loan, amounting to EUR 350,000, was secured in June 2023 to provide additional...

Scandinavian ChemoTech has secured a SEK 6 million growth loan from a larger financial institution in Sweden. The financing forms part of ChemoTech's long-term financial strategy and will support the Company's commercial expansion within Animal Care in North America and Europe. By strengthening sales and marketing capacity, the loan is expected to contribute to increased revenues and accelerate the Company's path toward profitability. It also enhances ChemoTech's financial flexibility by enabling other funds to be reallocated toward the continued development of the TSE platform.   The...

Lund, Sweden, June 2, 2026. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announced that Renée Aguiar-Lucander, CEO, Hansa Biopharma, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York, at 8:45 AM EDT on Thursday, June 4, 2026. If you are interested in meeting with Hansa's management, please contact Hansa Biopharma at ir@hansabiopharma.com. Event: Fireside chat at Jefferies Global Healthcare Conference Date, Time, and Place: Thursday June 4, 8:45-9:15 AM EDT, at the Marriott Marquis in New York Speaker: Renée Aguiar-...

Der US-amerikanische Pharma-Riese Eli Lilly bleibt auf Shopping-Tour. Neben zwei Lizenzdeals in Asien konnte das Unternehmen auch eine erweiterte Partnerschaft mit der schwedischen Camurus einfädeln. Für die Skandinavier ist die Erweiterung der Kollaboration vor allem aus finanzieller Sicht von enormer Bedeutung....

STOCKHOLM, SE AND CAMBRIDGE, MA / ACCESS Newswire / June 2, 2026 / Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 (AT2) receptor agoni......